Pediatric rheumatology

Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort

Pediatr Rheumatol Online JPublished Psychometric validation study within a prospective inception cohort

Authors' conclusion

The German versions of the PARQ and CARQ appear to have a good reliability and sufficient construct validity.

Study context

Population
Patients with newly diagnosed juvenile idiopathic arthritis (JIA) and their parents enrolled in the Inception Cohort Study (ICON), Germany; mean age 10.1 ± 3.7 years, disease duration 4.7 ± 0.8 years481 parents · 465 children
Participants
481 vs 465
Comparison
Parent-reported vs child-reported adherence
  • Parent Adherence Report Questionnaire (PARQ)n = 481
  • Child Adherence Report Questionnaire (CARQ)n = 465
Outcome
Reliability and construct validity of German PARQ/CARQ; adherence in JIA
Follow-up
4-year follow-up
Methodological detailstranslation and cross-cultural adaptation, test-retest reliability, construct validity
  • Translation and cross-cultural adaptation
  • Test-retest reliability
  • Construct validity

Performance

As reported in the abstract

Child ability total score for medication (0-100, 100 = best)

PARQ

73.1

mean · SD 23.3

CARQ

76.5

mean · SD 24.2

Further findings

Mean

OutcomePARQCARQ
Child ability total score for exercise (0-100) · 4-year follow-up85.6 (SD 16.5)90.3 (SD 15.0)
Child ability total score for splints (0-100) · 4-year follow-up72.9 (SD 24.2)82.9 (SD 16.5)

Adherence, helpfulness and barriers

Adolescents showed poorer adherence than children
About one third of parents and children reported medication errors
Perceived helpfulness highest for medication
Adverse effects reported as the greatest barrier to adherence

Original publication

Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort. Pediatr Rheumatol Online J. Published 12 April 2023. doi:10.1186/s12969-023-00811-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.